T/CASME 276-2022 Active Group standards

T/CASME 276-2022 Biopharmaceutical raw material R&D enterprise safety management specification

T/CASME 276-2022 Biopharmaceutical raw material R&D enterprise safety management specification

Publish Date: 2022-12-29 Implement Date: 2022-12-31 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us
Price: $ 20.00
Out of stock

Basic Information

Standard Code: T/CASME 276-2022
Standard Type: Group standards
Standard Status: Active
is_force_gb: no
CCS Name: Medicine, health, and labor protection
ICS Name: Other standards related to the organization and management of companies (enterprises)
Publish Date: 2022-12-29
Implement Date: 2022-12-31

Scope

Scope: This document applies to the safety management of internal R&D activities in biopharmaceutical raw material R&D enterprises; Main technical content: This document stipulates the basic requirements, safety operating procedures, safety education and training, safety risk management, hidden danger inspection and treatment, R&D process management, trial production management, facility and equipment management, accident management, emergency management, and evaluation and improvement of biopharmaceutical raw material R&D enterprises.

Development Information

Related Standards

Contact Us